CN115403675A - A kind of complexation and refining process of carboxymaltose iron - Google Patents
A kind of complexation and refining process of carboxymaltose iron Download PDFInfo
- Publication number
- CN115403675A CN115403675A CN202211039391.9A CN202211039391A CN115403675A CN 115403675 A CN115403675 A CN 115403675A CN 202211039391 A CN202211039391 A CN 202211039391A CN 115403675 A CN115403675 A CN 115403675A
- Authority
- CN
- China
- Prior art keywords
- solution
- reaction
- precipitation
- temperature
- carboxymaltose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 33
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 30
- 238000007670 refining Methods 0.000 title claims abstract description 13
- 238000010668 complexation reaction Methods 0.000 title claims description 10
- 238000003756 stirring Methods 0.000 claims abstract description 25
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 230000000536 complexating effect Effects 0.000 claims abstract description 11
- 238000005374 membrane filtration Methods 0.000 claims abstract description 8
- 238000004108 freeze drying Methods 0.000 claims abstract description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims abstract 6
- MFBBZTDYOYZJGB-HAONTEFVSA-L (2s,3s,4s,5r)-4-[(2r,3r,4r,5s,6r)-5-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoate;iron(3+);oxyg Chemical compound O.[OH-].[O-2].[Fe+3].O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H](O)CO)[C@@H](O)[C@H](O)C([O-])=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 MFBBZTDYOYZJGB-HAONTEFVSA-L 0.000 claims abstract 3
- 229960004131 ferric carboxymaltose Drugs 0.000 claims abstract 3
- 239000000243 solution Substances 0.000 claims description 62
- 238000006243 chemical reaction Methods 0.000 claims description 40
- 238000001556 precipitation Methods 0.000 claims description 31
- 239000000463 material Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 229920002774 Maltodextrin Polymers 0.000 claims description 15
- 239000005913 Maltodextrin Substances 0.000 claims description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 229940035034 maltodextrin Drugs 0.000 claims description 15
- 238000000108 ultra-filtration Methods 0.000 claims description 13
- 239000006228 supernatant Substances 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 11
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 11
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- 238000007254 oxidation reaction Methods 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 230000003647 oxidation Effects 0.000 claims description 7
- 239000000919 ceramic Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- 238000002161 passivation Methods 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 239000012670 alkaline solution Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 230000002572 peristaltic effect Effects 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 239000000084 colloidal system Substances 0.000 claims description 3
- 239000000498 cooling water Substances 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- 229960004887 ferric hydroxide Drugs 0.000 claims description 3
- IEECXTSVVFWGSE-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide Chemical compound [OH-].[O-2].[Fe+3] IEECXTSVVFWGSE-UHFFFAOYSA-M 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000012466 permeate Substances 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 238000009826 distribution Methods 0.000 abstract description 5
- 239000002105 nanoparticle Substances 0.000 abstract description 3
- 239000002245 particle Substances 0.000 abstract description 3
- 239000013585 weight reducing agent Substances 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 238000012869 ethanol precipitation Methods 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 238000001471 micro-filtration Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000005192 partition Methods 0.000 description 4
- 239000012465 retentate Substances 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 239000012527 feed solution Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010049040 Weight fluctuation Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- FWZTTZUKDVJDCM-CEJAUHOTSA-M disodium;(2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;iron(3+);oxygen(2-);hydroxide;trihydrate Chemical compound O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FWZTTZUKDVJDCM-CEJAUHOTSA-M 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- -1 iron ions Chemical class 0.000 description 1
- 229940032961 iron sucrose Drugs 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- MVZXTUSAYBWAAM-UHFFFAOYSA-N iron;sulfuric acid Chemical compound [Fe].OS(O)(=O)=O MVZXTUSAYBWAAM-UHFFFAOYSA-N 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/18—Oxidised starch
- C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
技术领域technical field
本发明属于药物领域,具体涉及一种羧基麦芽糖铁的络合与精制工艺。The invention belongs to the field of medicines, and in particular relates to a process for complexing and refining iron carboxymaltose.
背景技术Background technique
羧基麦芽糖铁是一种新型的纳米铁络合物,用氧化后的麦芽糖糊精(即本申请文件中所称“羧基麦芽糖”)将氢氧化铁胶体粒子稳定地络合在其中,控制铁的释出,铁离子能与铁转运蛋白和铁蛋白结合以发挥作用,并防止释放大量的游离铁,减少有毒氧化物的形成,能有效地提高轻到中度缺铁性贫血患者的Hb和血清铁蛋白浓度。Iron carboxymaltose is a new type of nano-iron complex. Iron hydroxide colloidal particles are stably complexed in it with oxidized maltodextrin (that is, "carboxymaltose" in this application document) to control the concentration of iron. Released, iron ions can combine with iron transport protein and ferritin to play a role, and prevent the release of a large amount of free iron, reduce the formation of toxic oxides, and can effectively improve the Hb and serum levels of patients with mild to moderate iron deficiency anemia ferritin concentration.
因此,与当前临床常见的补铁剂相比,羧基麦芽糖铁拥有与蔗糖铁相似的铁利用效率,但没有右旋糖酐铁会出现过敏反应的缺点。Therefore, compared with the current common clinical iron supplements, iron carboxymaltose has iron utilization efficiency similar to iron sucrose, but it does not have the disadvantage of iron dextran that may cause allergic reactions.
制备羧基麦芽糖铁的关键起始原料为麦芽糖糊精,以麦芽糖糊精为起始物料,经氧化、络合反应及精制,制得成品羧基麦芽糖铁。The key starting material for preparing carboxymaltose iron is maltodextrin, and the finished carboxymaltose iron is obtained through oxidation, complexation reaction and refining by using maltodextrin as the starting material.
目前行业内麦芽糖糊精原料的质量波动范围较大、分子量不稳定,稳定性放置过程中分子量下降趋势显著,给羧基麦芽糖铁的制备和工艺放大带来比较大的困扰,比如会造成产品羧基麦芽铁分子量分布批次波动较大、分子量分布集中度不高、分子量不稳定等。At present, the quality of maltodextrin raw materials in the industry has a large fluctuation range, unstable molecular weight, and a significant decline in molecular weight during the stability storage process, which brings relatively large troubles to the preparation of carboxymaltodextrin iron and process scale-up, for example, it will cause carboxymalt. The molecular weight distribution of iron has large fluctuations in batches, the concentration of molecular weight distribution is not high, and the molecular weight is unstable.
发明内容Contents of the invention
本发明针对上述存在的技术问题,通过对影响产品分子量的关键络合工艺各参数进行精准控制,然后采用程序升温法对络合后的多糖铁进行钝化,使其分子量趋于稳定,采用冻干工艺严格控制羧基麦芽糖铁中的残留溶剂和水分,使得其分子量在放置稳定性过程中保持稳定。The present invention aims at the above-mentioned technical problems, by precisely controlling the parameters of the key complexing process that affect the molecular weight of the product, and then adopting the temperature programming method to passivate the complexed polysaccharide iron to make its molecular weight tend to be stable. The dry process strictly controls the residual solvent and moisture in carboxymaltose iron, so that its molecular weight remains stable during the placement stability process.
一种羧基麦芽糖铁的络合与精制工艺,具体包括如下步骤:A complexing and refining process of carboxymaltose iron, specifically comprising the following steps:
(1)氧化:(1) Oxidation:
a)将麦芽糊精溶解后升温至30-40℃(优选为30℃),在搅拌下向其中滴加NaClO水溶液;a) After dissolving the maltodextrin, the temperature is raised to 30-40° C. (preferably 30° C.), and NaClO aqueous solution is added thereto dropwise under stirring;
b)NaClO水溶液滴加完后,在搅拌下,向其中加入溴化钠固体,反应过程中用pH计在线监测反应液的pH值,始终调节溶液pH在10.0-11.0;同时在线检测反应液的粘度变化,待粘度降至65-70m Pa·s时,调节反应液的最终pH值至3.0-5.0终止反应;b) After the NaClO aqueous solution is added dropwise, under stirring, add sodium bromide solid therein, monitor the pH value of the reaction solution online with a pH meter during the reaction, and always adjust the pH of the solution at 10.0-11.0; simultaneously detect the pH of the reaction solution online Viscosity changes, when the viscosity drops to 65-70mPa·s, adjust the final pH value of the reaction solution to 3.0-5.0 to terminate the reaction;
c)反应停止后,向其中加入无水乙醇进行沉淀,待沉淀完全后,除上清,加水溶解;然后继续向溶解后溶液中加入无水乙醇至沉淀完全;沉淀完毕,除上清,加水溶解得到25wt%-30wt%的中间体溶液,进行下一步陶瓷膜过滤步骤;c) After the reaction stops, add absolute ethanol to it for precipitation. After the precipitation is complete, remove the supernatant and add water to dissolve; then continue to add absolute ethanol to the dissolved solution until the precipitation is complete; after the precipitation is complete, remove the supernatant and add water Dissolving to obtain an intermediate solution of 25wt%-30wt%, and performing the next ceramic membrane filtration step;
(2)陶瓷膜过滤纯化:(2) Ceramic membrane filtration and purification:
A.选择孔径为3Kd-5Kd的超滤膜包对上述步骤(1)得到的中间体溶液进行超滤;当超滤至透过液体积占物料总重的30%-40%时,取截留液物料样品进行分子量检测,当所测中间体分子量的峰高比值1.5≥H2/H1≥1.2时,停止超滤;A. select the ultrafiltration membrane bag that the pore size is 3Kd-5Kd to carry out ultrafiltration to the intermediate solution that above-mentioned step (1) obtains; The liquid material sample is tested for molecular weight, and when the peak height ratio of the molecular weight of the measured intermediate is 1.5≥H2/H1≥1.2, the ultrafiltration is stopped;
B.取上述步骤A所得截留液,向其中加入无水乙醇进行沉淀,沉淀完全后除上清,接着在30℃-40℃下,真空干燥得中间体羧基麦芽糖;B. Take the retentate obtained in the above step A, add absolute ethanol to it for precipitation, remove the supernatant after the precipitation is complete, and then vacuum-dry at 30°C-40°C to obtain the intermediate carboxymaltose;
(3)利用得到的中间体羧基麦芽糖经过络合钝化、精制、冻干后制备得到羧基麦芽糖铁。(3) Using the obtained intermediate carboxymaltose to prepare carboxymaltose iron through complexation passivation, refining and freeze-drying.
进一步的,所述沉淀条件为:加入溶解液体积5-6倍的无水乙醇,沉淀时间为5-8h,沉淀具体操作为:加入无水乙醇后搅拌15min,然后静置50min。Further, the precipitation condition is: add absolute ethanol with 5-6 times the volume of the solution, and the precipitation time is 5-8 hours. The specific operation of precipitation is: add absolute ethanol, stir for 15 minutes, and then stand still for 50 minutes.
进一步的,所述麦芽糊精为DE值16-20的麦芽糊精。Further, the maltodextrin is maltodextrin with a DE value of 16-20.
进一步的,所述麦芽糊精与NaClO、溴化钠的加入量比为100:(10-15):1,优选为100:10.4:1。Further, the ratio of maltodextrin to NaClO and sodium bromide is 100:(10-15):1, preferably 100:10.4:1.
更进一步的,所述NaClO水溶液的浓度为5.2wt%,其加入速度为(1.5-2.0)L/h。Further, the concentration of the NaClO aqueous solution is 5.2wt%, and its feeding rate is (1.5-2.0) L/h.
进一步的,所述步骤(3)的具体操作如下:Further, the specific operations of the step (3) are as follows:
(一)络合钝化工序:(1) Complexation passivation process:
a)将FeCl3.6H2O配制成FeCl3溶液放入反应罐中,在搅拌状态下向其中加入步骤(2)得到的中间体羧基麦芽糖,搅拌至混合均匀,然后调节反应料液的温度至30-40℃,搅拌下(优选搅拌转速为350rpm),利用蠕动泵将Na2CO3溶液迅速滴加至反应液中,以制备氢氧化铁胶体;a) Prepare FeCl 3 .6H 2 O into a FeCl 3 solution and put it in a reaction tank, add the intermediate carboxy maltose obtained in step (2) to it under stirring, stir until the mixture is uniform, and then adjust the temperature of the reaction feed liquid To 30-40°C, under stirring (preferably the stirring speed is 350rpm), use a peristaltic pump to quickly drop Na2CO3 solution into the reaction solution to prepare ferric hydroxide colloid ;
b)上述Na2CO3溶液滴加完毕后,向其中滴加碱性溶液(优选为6mol/LNaOH溶液)调节反应液的pH至10.5-11.0,碱性溶液的滴加速度为碳酸钠溶液滴加速度的一半;b) above-mentioned Na 2 CO 3 After the solution has been added dropwise, an alkaline solution (preferably 6mol/L NaOH solution) is added dropwise thereto to adjust the pH of the reaction solution to 10.5-11.0, and the rate of addition of the alkaline solution is the rate of addition of the sodium carbonate solution half of
c)待料液pH值调节至10.5-11.0后,密封反应罐,将料液温度升至50±2℃并保持50min;然后将料液温度升至68±2℃并保温1h;保温完毕后,调节络合体系的pH=6.0±0.1,升温至88±2℃保持60min,反应过程中,保持体系的pH=6.1±0.1;接着继续升温至98±2℃保持50min,此阶段中始终调节pH至6.1±0.1;最后将反应罐加压至5个大气压、蒸汽加热升温至121±2℃,继续保持17min;反应完后,加冷却水使物料降温至室温,再调节物料的pH=6.1±0.1后备用;c) After the pH value of the feed liquid is adjusted to 10.5-11.0, seal the reaction tank, raise the temperature of the feed liquid to 50±2°C and keep it for 50 minutes; then raise the temperature of the feed liquid to 68±2°C and keep it warm for 1 hour; after the heat preservation is completed , adjust the pH of the complexation system=6.0±0.1, raise the temperature to 88±2°C and keep it for 60min, during the reaction process, keep the pH of the system=6.1±0.1; pH to 6.1±0.1; finally, pressurize the reaction tank to 5 atmospheres, heat the steam to 121±2°C, and keep it for 17 minutes; after the reaction, add cooling water to cool the material to room temperature, and then adjust the pH of the material to 6.1 Reserved after ±0.1;
(二)精制工序(2) Refining process
将步骤(一)得到的物料过滤后(优选为经过0.22微米滤芯),取滤液,向其中加入滤液等体积的无水乙醇进行沉淀;沉淀完毕,去除上清,剩余物料进行离心操作,收集离心后的沉淀物,加水溶解,搅拌均匀后再次进行调节溶液的pH=6.1±0.1,接着经过过滤所得固体进行冻干操作;After the material obtained in step (1) is filtered (preferably through a 0.22 micron filter element), the filtrate is taken, and anhydrous ethanol equal to the volume of the filtrate is added to it for precipitation; The final precipitate was dissolved in water, stirred evenly, and then the pH of the solution was adjusted to 6.1 ± 0.1, and then the obtained solid was filtered and freeze-dried;
(三)冻干(3) freeze-drying
a)前、后箱制冷:将步骤(二)所得物料置于冻干机内,关闭冻干机门,关闭放气阀,打开导热循环,开启压缩机,开启阀门,开始前箱制冷至-30—-35℃;待前箱制冷至-30—-35℃,关闭导热循环,打开后箱阀门给后箱制冷至-45—-50℃,并在此温度下保持2h;a) Cooling of the front and rear boxes: put the material obtained in step (2) in the freeze dryer, close the door of the freeze dryer, close the air release valve, open the heat conduction cycle, turn on the compressor, open the valve, and start the front box refrigeration to - 30—-35°C; when the front box is cooled to -30—-35°C, close the heat conduction cycle, open the valve of the back box to cool the back box to -45—-50°C, and keep at this temperature for 2 hours;
b)接着开启中隔阀,开启真空泵使真空度降至50pa以下后,立即打开导热循环,使前箱升温至35-40℃,然后在此温度下保持2h,保温完毕,关闭压缩机,关闭真空泵,关闭中隔阀,关闭导热循环,打开放气阀开始出料,收集冻干物料,称重包装得羧基麦芽糖铁成品。b) Then open the partition valve, turn on the vacuum pump to reduce the vacuum degree to below 50pa, then immediately turn on the heat conduction cycle to raise the temperature of the front box to 35-40°C, and then keep it at this temperature for 2 hours. After the heat preservation is completed, turn off the compressor and turn off Vacuum pump, close the partition valve, close the heat conduction cycle, open the vent valve to start discharging, collect the freeze-dried material, weigh and pack to obtain the finished carboxymaltose iron product.
进一步的,上述各步骤中,用6mol/L HCl溶液或者6mol/L NaOH溶液调节pH。Further, in each of the above steps, the pH is adjusted with 6 mol/L HCl solution or 6 mol/L NaOH solution.
进一步的,所述羧基麦芽糖与FeCl3.6H2O、Na2CO3的加入量比为100:(50-70):(50-70),优选为100:60:57。Further, the ratio of carboxyl maltose to FeCl 3 .6H 2 O and Na 2 CO 3 is 100:(50-70):(50-70), preferably 100:60:57.
更进一步的,所述Na2CO3溶液的浓度为10%,其加入速度为(1-2.0)L/h。Furthermore, the concentration of the Na 2 CO 3 solution is 10%, and its feeding rate is (1-2.0) L/h.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
(1)通过对影响络合的温度、pH值、碱滴加速度、搅拌转速进行精准控制,使得羧基麦芽糖铁纳米颗粒均匀组装,分子量分布符合要求,且放置过程中无显著变化。(1) Through precise control of the temperature, pH value, alkali dropping speed, and stirring speed that affect the complexation, the carboxymaltose iron nanoparticles are uniformly assembled, the molecular weight distribution meets the requirements, and there is no significant change during the placement process.
(2)采用程序升温法对羧基麦芽糖铁颗粒进行钝化,使得成品分子量降低趋势得到有效控制。(2) Carboxymaltose iron particles are passivated by temperature programming method, so that the molecular weight reduction trend of the finished product is effectively controlled.
(3)综合采用乙醇沉淀、微孔滤膜过滤和程序冻干工艺,对羧基麦芽糖铁中的可见异物、溶剂残留、水分等进行有效控制,使得产品稳定性进一步提高,从而使长期稳定性分子量下降趋势得到解决。(3) Comprehensively adopt ethanol precipitation, microporous membrane filtration and programmed freeze-drying process to effectively control the visible foreign matter, solvent residue, moisture, etc. in iron carboxymaltose, so that the product stability is further improved, so that the long-term stable molecular weight The downtrend is resolved.
具体实施方式Detailed ways
以下通过具体实施例对本发明的技术方案作进一步详细说明。The technical solution of the present invention will be described in further detail below through specific examples.
实施例中所用原料药用麦芽糖糊精购自西王集团,DE值18。The medicinal maltodextrin used in the examples was purchased from Xiwang Group with a DE value of 18.
实施例1一种羧基麦芽糖铁的络合与精制工艺,依次包括如下步骤:Embodiment 1 A kind of complexing and refining process of carboxyl maltose iron comprises the following steps successively:
(1)氧化:(1) Oxidation:
a)称取药用麦芽糊精400g,在烧杯中加水溶解使其质量浓度为30%,继续搅拌4-6h至完全溶解(本实施例中搅拌5小时),然后升温至30℃,在搅拌下向其中缓慢、均匀地加入NaClO溶液(浓度5.2wt%)800ml,25-30min加毕。a) Weigh 400g of medicinal maltodextrin, add water to dissolve it in a beaker to make the mass concentration 30%, continue to stir for 4-6h until it is completely dissolved (stirring for 5 hours in this example), then heat up to 30°C, and stir Slowly and uniformly add 800ml of NaClO solution (concentration: 5.2wt%) thereinto, and finish adding in 25-30min.
b)NaClO溶液滴加完后,在搅拌下,向其中加入溴化钠固体4g进行反应,反应过程中用pH计在线监测反应液的pH值,用6mol/L盐酸调节溶液pH在10.0-11.0;同时在线检测反应液的粘度变化,待粘度降至65-70m Pa·s时,用6mol/L盐酸调节最终pH值至3.0-5.0(本实施例中,当粘度降至68m Pa·s时,调节pH值至4.0)。b) After the NaClO solution has been added dropwise, under stirring, add 4g of sodium bromide solid to it for reaction, monitor the pH value of the reaction solution online with a pH meter during the reaction, and adjust the pH of the solution at 10.0-11.0 with 6mol/L hydrochloric acid ; Simultaneously on-line detection of the viscosity change of the reaction solution, when the viscosity drops to 65-70m Pa s, adjust the final pH value to 3.0-5.0 with 6mol/L hydrochloric acid (in this embodiment, when the viscosity drops to 68m Pa s , adjust the pH to 4.0).
c)接着向其中加入5倍于料液体积的无水乙醇进行沉淀,沉淀时间6h,沉淀完毕,除上清,加水溶解成50%的浓度;然后继续向溶解后溶液中加入6倍体积的无水乙醇,继续沉淀6h。c) Then add 5 times of absolute ethanol to the volume of the feed solution for precipitation, the precipitation time is 6h, after the precipitation is complete, remove the supernatant, add water to dissolve into a concentration of 50%; then continue to add 6 times the volume of the solution to the dissolved solution Absolute ethanol, continue to precipitate for 6h.
d)沉淀完毕,除上清,加水溶解至得到25wt%-30wt%的中间体溶液,进行下一步陶瓷膜过滤步骤。d) After the precipitation is completed, remove the supernatant, add water to dissolve until a 25wt%-30wt% intermediate solution is obtained, and proceed to the next ceramic membrane filtration step.
(2)陶瓷膜过滤纯化:(2) Ceramic membrane filtration and purification:
a)选择孔径为3Kd超滤膜包对上述中间体溶液进行超滤;当超滤至透过液体积占物料总重的40%时,取截留液物料样品进行分子量检测,当所测中间体分子量的峰高比值1.5≥H2/H1≥1.2时,停止超滤。a) The 3Kd ultrafiltration membrane package is selected to perform ultrafiltration on the above-mentioned intermediate solution; when the ultrafiltration reaches 40% of the total weight of the permeate, the retentate material sample is taken for molecular weight detection, and when the measured intermediate When the peak height ratio of molecular weight is 1.5≥H2/H1≥1.2, stop ultrafiltration.
b)取上述步骤a)所得截留液,加入5倍于料液体积的无水乙醇进行沉淀,沉淀时间6h,沉淀完毕,除上清,接着在30℃条件下,真空干燥9个小时得中间体羧基麦芽糖。b) Take the retentate obtained in the above step a), add 5 times the volume of the feed solution in absolute ethanol for precipitation, the precipitation time is 6h, after the precipitation is complete, remove the supernatant, and then vacuum-dry for 9 hours at 30°C to obtain the intermediate Body carboxy maltose.
(3)络合钝化工序:(3) Complexation passivation process:
a)称取Na2CO3 228g,加水配制成浓度为10wt%的Na2CO3溶液;a) Weigh 228g of Na 2 CO 3 , add water to prepare a Na 2 CO 3 solution with a concentration of 10 wt %;
b)称取FeCl3.6H2O 400g,加水溶解成FeCl3浓度为20%的溶液,将其放入反应罐中,在搅拌状态下向其中加入步骤(2)得到的中间体羧基麦芽糖240g,继续搅拌30min至混合均匀,然后调节反应料液的温度至40±1℃,搅拌转速为350rpm,利用蠕动泵将步骤a)配制好的Na2CO3溶液在2.0h之内迅速滴加至反应液中,以制备氢氧化铁胶体;b) Weigh 400g of FeCl 3 .6H 2 O, add water to dissolve it into a solution with a FeCl 3 concentration of 20%, put it into a reaction tank, and add 240g of the intermediate carboxymaltose obtained in step (2) to it under stirring , continue to stir for 30 minutes until the mixture is uniform, then adjust the temperature of the reaction feed liquid to 40±1°C, and the stirring speed is 350rpm, and use a peristaltic pump to quickly drop the Na 2 CO 3 solution prepared in step a) to the In the reaction solution, to prepare ferric hydroxide colloid;
c)上述Na2CO3溶液滴加完毕后,向其中滴加6mol/L NaOH溶液调节反应液的pH,NaOH溶液用蠕动泵匀速滴加,滴加速度为碳酸钠溶液滴加速度的一半,最终使料液pH值调至10.5-11.0;c) above-mentioned Na 2 CO 3 After the solution has been added dropwise, add 6mol/L NaOH solution dropwise therein to adjust the pH of the reaction solution, and the NaOH solution is added dropwise at a constant speed with a peristaltic pump, and the drop rate is half of the drop rate of the sodium carbonate solution, finally making The pH value of the feed liquid is adjusted to 10.5-11.0;
d)待料液pH值调节至10.5-11.0后,密封反应罐,将料液温度升至50±2℃并保持50min;然后将料液温度升至68±2℃并保温1h;保温完毕后,用6mol/L HCl溶液调节络合体系的pH=6.0±0.1,升温至88±2℃,并在88±2℃下保持60min,反应过程中,保持体系的pH=6.1±0.1;接着继续升温至98±2℃,在此温度下保持50min,此阶段中始终用6mol/L HCl溶液调节pH至6.1±0.1;最后将反应罐加压至5个大气压、蒸汽加热升温至121±2℃,继续保持17min。d) After the pH value of the feed liquid is adjusted to 10.5-11.0, seal the reaction tank, raise the temperature of the feed liquid to 50±2°C and keep it for 50 minutes; then raise the temperature of the feed liquid to 68±2°C and keep it warm for 1 hour; after the heat preservation is completed , use 6mol/L HCl solution to adjust the pH of the complex system=6.0±0.1, raise the temperature to 88±2°C, and keep it at 88±2°C for 60min, during the reaction, keep the pH of the system=6.1±0.1; then continue Raise the temperature to 98±2°C and keep it at this temperature for 50 minutes. During this stage, use 6mol/L HCl solution to adjust the pH to 6.1±0.1; finally pressurize the reaction tank to 5 atmospheres, heat the steam to 121±2°C , continue to maintain 17min.
e)反应完后,加冷却水使物料降温至室温,再用6mol/L HCl溶液调节物料的pH=6.1±0.1后备用。e) After the reaction, add cooling water to cool the material to room temperature, and then use 6mol/L HCl solution to adjust the pH of the material to 6.1±0.1 for later use.
(4)精制工序(4) Refining process
a)将步骤(3)得到的物料用0.22微米滤芯过滤后,准确量取滤液体积,向其中加入滤液等体积的无水乙醇进行沉淀(沉淀具体操作为:加入无水乙醇后搅拌15min,然后静置50min)。a) After the material obtained in step (3) is filtered with a 0.22 micron filter element, the volume of the filtrate is accurately measured, and dehydrated alcohol of equal volume to the filtrate is added thereto for precipitation (the specific operation of the precipitation is: stir for 15 minutes after adding dehydrated alcohol, then Stand still for 50min).
b)沉淀完毕,去除上清,剩余物料进行离心操作,收集离心后的沉淀物,加纯化水溶解成20%浓度,搅拌均匀后再次进行调节pH=6.1±0.1,接着经过0.22微米滤芯过滤,所得固体进行冻干操作。b) After the precipitation is complete, remove the supernatant, centrifuge the remaining materials, collect the centrifuged sediment, add purified water to dissolve it to a concentration of 20%, stir it evenly, adjust the pH=6.1±0.1 again, and then filter through a 0.22 micron filter element, The resulting solid was lyophilized.
(5)冻干(5) freeze-dried
a)前、后箱制冷:将步骤(4)所得物料置于冻干机内,关闭冻干机门,关闭放气阀,打开导热循环,开启压缩机,开启阀门,开始前箱制冷至-30—-35℃;待前箱制冷至-30—-35℃,关闭导热循环,打开后箱阀门给后箱制冷至-45—-50℃,并在此温度下保持2h。a) Cooling of the front and rear boxes: put the material obtained in step (4) in the freeze dryer, close the door of the freeze dryer, close the air release valve, open the heat conduction cycle, turn on the compressor, open the valve, and start the front box refrigeration to - 30—-35°C; when the front box is cooled to -30—-35°C, close the heat conduction cycle, open the valve of the back box to cool the back box to -45—-50°C, and keep at this temperature for 2 hours.
b)接着开启中隔阀,开启真空泵使真空度降至50pa以下后,立即打开导热循环,使前箱升温至35-40℃,然后在此温度下保持2h,保温完毕,关闭压缩机,关闭真空泵,关闭中隔阀,关闭导热循环,打开放气阀开始出料。b) Then open the partition valve, turn on the vacuum pump to reduce the vacuum degree to below 50pa, then immediately turn on the heat conduction cycle to raise the temperature of the front box to 35-40°C, and then keep it at this temperature for 2 hours. After the heat preservation is completed, turn off the compressor and turn off Vacuum pump, close the partition valve, close the heat conduction cycle, open the air release valve and start discharging.
c)收集冻干物料,称重包装得羧基麦芽糖铁成品。c) Collect the freeze-dried materials, weigh and pack to obtain the finished carboxymaltose iron product.
申请人通过研究发现,应用本发明的工艺进行羧基麦芽糖中间品制备时,选择DE值分布范围为16-20的麦芽糖糊精为起始原料,可以有效避免因原料DE值波动大,从而对后续的氧化、络合、纯化等工艺造成影响。The applicant has found through research that when applying the process of the present invention to the preparation of carboxy maltose intermediates, choosing maltodextrin with a DE value distribution range of 16-20 as the starting material can effectively avoid large fluctuations in the DE value of the raw material, thereby affecting the follow-up Oxidation, complexation, purification and other processes are affected.
本发明可以通过控制反应液至特定的粘度,从而控制氧化终点,进一步通过对料液粘度进行在线检测,避免对分子量进行繁琐的离线检测,准确监控氧化反应终点,使得中间体羧基麦芽糖生产工艺更加可控,避免中间体分子量波动对后续络合造成影响。The present invention can control the oxidation end point by controlling the reaction liquid to a specific viscosity, and further, through on-line detection of the viscosity of the material liquid, avoid cumbersome off-line detection of the molecular weight, accurately monitor the end point of the oxidation reaction, and make the production process of the intermediate carboxy maltose more efficient. Controllable, avoiding the impact of the molecular weight fluctuation of the intermediate on the subsequent complexation.
通过采用孔径为3Kd的超滤膜包进行超滤,有效去除氧化产生的寡糖小分子和氯离子等杂质,使得中间体羧基麦芽糖分散系数为1.3,氯化钠含量4.6%。By using ultrafiltration membrane bag with a pore size of 3Kd for ultrafiltration, impurities such as small oligosaccharide molecules and chloride ions produced by oxidation are effectively removed, so that the intermediate carboxymaltose has a dispersion coefficient of 1.3 and a sodium chloride content of 4.6%.
表1Table 1
表1中各样品分别为实施例1制得的羧基麦芽糖铁样品,以及该样品在室温下放置6个月和12个月后得检测结果。Each sample in Table 1 is the iron carboxymaltose sample prepared in Example 1, and the test results obtained after the sample was placed at room temperature for 6 months and 12 months.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211039391.9A CN115403675A (en) | 2022-08-29 | 2022-08-29 | A kind of complexation and refining process of carboxymaltose iron |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211039391.9A CN115403675A (en) | 2022-08-29 | 2022-08-29 | A kind of complexation and refining process of carboxymaltose iron |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115403675A true CN115403675A (en) | 2022-11-29 |
Family
ID=84161325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211039391.9A Pending CN115403675A (en) | 2022-08-29 | 2022-08-29 | A kind of complexation and refining process of carboxymaltose iron |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115403675A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498539A (en) * | 2018-05-03 | 2018-09-07 | 东营天东制药有限公司 | A kind of preparation method of water solubility chalybeate complex bulk pharmaceutical chemicals |
CN113004428A (en) * | 2019-12-20 | 2021-06-22 | 金陵药业股份有限公司 | Preparation method of carboxyl ferric maltose |
CN113004429A (en) * | 2019-12-20 | 2021-06-22 | 金陵药业股份有限公司 | Refining method of carboxyl ferric maltose |
CN216499363U (en) * | 2021-12-27 | 2022-05-13 | 滨州学院 | A kind of maltodextrin oxide intermediate separation and purification device |
CN216704374U (en) * | 2021-12-27 | 2022-06-10 | 滨州学院 | But on-line control's carboxyl maltose iron complex apparatus for producing |
-
2022
- 2022-08-29 CN CN202211039391.9A patent/CN115403675A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498539A (en) * | 2018-05-03 | 2018-09-07 | 东营天东制药有限公司 | A kind of preparation method of water solubility chalybeate complex bulk pharmaceutical chemicals |
CN113004428A (en) * | 2019-12-20 | 2021-06-22 | 金陵药业股份有限公司 | Preparation method of carboxyl ferric maltose |
CN113004429A (en) * | 2019-12-20 | 2021-06-22 | 金陵药业股份有限公司 | Refining method of carboxyl ferric maltose |
CN216499363U (en) * | 2021-12-27 | 2022-05-13 | 滨州学院 | A kind of maltodextrin oxide intermediate separation and purification device |
CN216704374U (en) * | 2021-12-27 | 2022-06-10 | 滨州学院 | But on-line control's carboxyl maltose iron complex apparatus for producing |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107467662B (en) | Water-soluble quercetin nanoparticle and preparation method thereof | |
CN106265596A (en) | Supercritical anti-solvent prepares the method for naringenin/hydroxypropyl beta cyclodextrin microcapsule | |
CN102532304A (en) | Preparation method of human serum albumin | |
CN1273382C (en) | Method for preparing Nano silicon dioxide | |
CN103445282B (en) | Preparation method of corn peptide glycosylation product nano particles embedding lipid-soluble vitamins | |
CN115403675A (en) | A kind of complexation and refining process of carboxymaltose iron | |
CN106432389A (en) | Method for preparing estradiol ultrafine particles with supercritical anti-solvent technology | |
CN115380986B (en) | Tartary buckwheat protein nanoparticles and preparation method thereof | |
CN102876765A (en) | Method for preparing antioxidant peptide with waste tea leaves | |
CN108294164A (en) | A kind of method and system of the 7S albumen of preparation of industrialization soybean protein | |
CN115322265A (en) | Carboxyl maltose controlled oxidation and purification process | |
CN108251487B (en) | Preparation method of Sinkiang black bee royal jelly glutelin enzymolysis product with antioxidant activity | |
CN109796470A (en) | A kind of preparation method of high-purity cefoperazone sodium micro mist | |
CN108864271B (en) | Preparation method of iron protein succinate | |
CN216704374U (en) | But on-line control's carboxyl maltose iron complex apparatus for producing | |
CN108251486B (en) | Preparation method of Xinjiang black bee royal jelly globulin enzymolysis product with antioxidant activity | |
CN104014276B (en) | A kind of precipitation Granulation Equipments for long chain macromolecule biomaterial | |
CN113248752A (en) | Preparation method of bacterial cellulose dissolution regeneration film | |
CN111955599A (en) | Preparation method of acid-soluble soybean protein-chitosan nanoparticles | |
CN114349872B (en) | Preparation process of oxidized regenerated cellulose material | |
CN221071372U (en) | Silk protein solution production system | |
CN216320458U (en) | Filter-pressing stable system is used in carragheen preparation | |
CN112246297A (en) | Wheat pretreatment process for reducing dust generation amount in flour processing | |
CN108619153A (en) | Composition containing dexrazoxane and its lyophilized preparation | |
CN117362464A (en) | Method for modifying lotus root polysaccharide through acetylation and reaction process control device thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221129 |